The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Drug: STAVUDINE.     Injury: Foetal exposure during pregnancy     Quarter: 2016Q3

Total Records: 32     Number of Pages: 2

Event ID DRUGNAME PT Drug Manufacturer Patient Age Sex Weight Date (YYYYMMDD) Country
119152632 STAVUDINE. Foetal exposure during pregnancy BRISTOL MYERS SQUIBB 0.00 DY M 2 KG 20160825 DE
119152992 STAVUDINE. Foetal exposure during pregnancy BRISTOL MYERS SQUIBB 0.00 DY F 2 KG 20160825 DE
119162782 STAVUDINE. Foetal exposure during pregnancy BRISTOL MYERS SQUIBB 0.00 DY F 1 KG 20160825 US
119178342 STAVUDINE. Foetal exposure during pregnancy BRISTOL MYERS SQUIBB 0.00 F 0 20160901 US
125231121 STAVUDINE. Foetal exposure during pregnancy BRISTOL MYERS SQUIBB 0.00 DY M 2 KG 20160701 PR
125797441 STAVUDINE. Foetal exposure during pregnancy CIPLA 0.00 0 20160721 IN
126282571 STAVUDINE. Foetal exposure during pregnancy CIPLA 0.00 0 20160808 IT
126282771 STAVUDINE. Foetal exposure during pregnancy CIPLA 0.00 0 20160808 IT
126283311 STAVUDINE. Foetal exposure during pregnancy CIPLA 0.00 0 20160808 IT
126283671 STAVUDINE. Foetal exposure during pregnancy CIPLA 0.00 0 20160808 IT
126894951 STAVUDINE. Foetal exposure during pregnancy ROCHE 0.00 0 20160826 US
127304281 STAVUDINE. Foetal exposure during pregnancy ABBVIE 0.00 0 20160909 COUNTRY NOT SPECIFIED

Total Records: 32     Number of Pages: 2